Kevin Lee Freeman serves as Executive at Health Catalyst, Inc., where they oversee executive responsibilities. Since joining the company, Kevin Lee Freeman has executed 17 insider transactions totaling $103.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 1, 2025 involved selling 16,401 shares valued at $47.6K.
Kevin Lee Freeman currently holds 358,686 shares of Health Catalyst, Inc. (HCAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Lee Freeman has been a net seller of HCAT stock. They have purchased $0 and sold $103.1K worth of shares.
Kevin Lee Freeman's most recent insider trade was on Dec 1, 2025, when they sold 16,401 shares at $2.90 per share.
Get notified when new Form 4 filings are submitted
| $3.36 |
| Discretionary |
| Sep 3, 2024 | HCAT | $54.1K | Sale | 7,500 | $7.22 | Discretionary |
| Sep 3, 2024 | HCAT | $20.2K | Payment | 2,772 | $7.27 | Discretionary |
| Jun 11, 2024 | HCAT | $49.0K | Sale | 7,500 | $6.53 | Planned |
| Jun 3, 2024 | HCAT | $19.3K | Payment | 2,951 | $6.53 | Discretionary |
| Mar 1, 2024 | HCAT | $36.5K | Payment | 4,540 | $8.05 | Discretionary |
| Feb 20, 2024 | HCAT | $0 | Award | 3,334 | $N/A | Discretionary |
| Feb 20, 2024 | HCAT | $0 | Award | 110,000 | $N/A | Discretionary |
| Dec 1, 2023 | HCAT | $21.8K | Payment | 2,921 | $7.45 | Discretionary |
| Sep 1, 2023 | HCAT | $99.7K | Payment | 8,460 | $11.78 | Discretionary |
| Jun 1, 2023 | HCAT | $11.7K | Payment | 1,038 | $11.24 | Discretionary |
| Mar 1, 2023 | HCAT | $0 | Award | 1,264 | $N/A | Discretionary |
| Mar 1, 2023 | HCAT | $22.4K | Payment | 1,569 | $14.29 | Discretionary |
| Mar 1, 2023 | HCAT | $0 | Award | 1,819 | $N/A | Discretionary |
| Dec 1, 2022 | HCAT | $26.0K | Payment | 2,446 | $10.65 | Discretionary |
| Sep 8, 2022 | HCAT | $0 | Award | 120,000 | $N/A | Discretionary |